EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
Source: https://www.pehub.com/large-market-deal-of-the-year-eqt-and-aldevron/
Powered by WPeMatico
Securities offered through Burch & Company, Inc. member FINRA/SiPC 4151 N Mulberry Drive, Suite 435 Kansas City, MO 64116
Apex Partners and Burch & Company are not affiliated. Any advisory services discussed on this site that are required to be performed by a registered broker-dealer shall be performed by Burch & Company, Inc., through its registered agents, Barry Harbour or Jim McCoy. Apex Partners is not registered as a broker or dealer and therefore does not perform services that involve securities.
Comments are closed.